Table 6.

Completion Rate of Chemotherapy and Dose Reduction or Discontinuation Due to CIPN.

	Group A (later GJG administration)	Group B (prophylactic GJG administration)	P value
	n = 26	n = 27
Completion rate of chemotherapy	21 (80.8%)	22 (81.5%)	1.0
Dose reduction	6 (23.1%)	4 (14.8%)	.773
Neurotoxicity	4 (15.4%)	2 (7.4%)
Other than neurotoxicity	2 (7.7%)	2 (7.4%)
Discontinuation	5 (19.2%)	5 (18.5%)	.472
Neurotoxicity	2 (7.7%)	0
Other than neurotoxicity	3 (11.5%)	5 (18.5%)

Abbreviations: CIPN, chemotherapy-induced peripheral neuropathy; GJG, Goshajinkigan.